10-Q: James River Group Returns to Profitability in Q3 2025

James River Group Holdings, Ltd. reported a significant turnaround in its third-quarter 2025 financial results, achieving underwriting profitability and positive net income, driven by strong performance in its Excess and Surplus Lines segment.

Summary

• Achieved net income of $1.0 million for Q3 2025, a substantial improvement from a net loss of $39.4 million in Q3 2024.
• Reported adjusted net operating income of $17.4 million for Q3 2025, compared to an adjusted net operating loss of $28.2 million in Q3 2024.
• Underwriting profit reached $8.9 million for Q3 2025, with a combined ratio of 94.0%, a significant improvement from an underwriting loss of $56.8 million and a combined ratio of 135.5% in Q3 2024.
• The Excess and Surplus Lines segment generated an underwriting profit of $16.4 million (combined ratio of 88.3%) in Q3 2025, reversing a $50.2 million loss in Q3 2024.
• Net favorable reserve development of $2.6 million was recorded in Q3 2025, compared to $56.9 million of net adverse development in Q3 2024.
• Gross written premiums declined by 28.2% to $237.3 million in Q3 2025, and net written premiums decreased by 16.7% to $122.7 million.
• Net investment income decreased by 7.0% to $21.9 million in Q3 2025.
• Tangible common equity increased by 24.2% for the nine months ended September 30, 2025, reaching $378.4 million.
• The company's leverage ratio stood at 28.5% at September 30, 2025, remaining below the maximum permitted 35.0%.

Sentiment

Score: 7

Explanation: The company demonstrated a strong turnaround in underwriting profitability and net income compared to the prior year, driven by favorable reserve development and strategic actions like the JRG Re sale and ADCs. However, declining premium volumes, particularly in Specialty Admitted Insurance, and a negative A.M. Best outlook present headwinds.

Positives

• Significant improvement in net income and adjusted net operating income for both the three and nine-month periods ended September 30, 2025.
• Return to underwriting profitability with a combined ratio of 94.0% for Q3 2025 and 97.4% for the nine months ended September 30, 2025.
• The Excess and Surplus Lines segment achieved a strong underwriting profit of $16.4 million in Q3 2025, with an 88.3% combined ratio.
• Recorded $2.6 million of net favorable reserve development in Q3 2025, indicating improved loss reserving accuracy.
• Tangible equity and tangible common equity saw healthy increases, reflecting balance sheet strength.
• Successful disposition of the Casualty Reinsurance segment (JRG Re) on April 16, 2024, streamlining operations.
• Established a strategic relationship with Enstar, including an Adverse Development Cover (E&S Top Up ADC) providing additional loss coverage up to $75.0 million.
• The planned domestication to Delaware is expected to lower the effective tax rate in future periods.
• Investment portfolio remains strong with 100.0% of fixed maturity securities rated BBBor better (investment grade).

Negatives

• Gross written premiums declined by 28.2% in Q3 2025 and 15.3% for the nine months ended September 30, 2025, primarily due to reduced activity in the Specialty Admitted Insurance segment.
• The Specialty Admitted Insurance segment shifted to an underwriting loss of $352,000 in Q3 2025, with a combined ratio of 104.3%.
• Net investment income decreased by 7.0% in Q3 2025 and 12.2% for the nine months ended September 30, 2025, due to lower yields and reduced invested assets.
• Common share dividends were significantly reduced from $0.05 to $0.01 per share quarterly.
• The A.M. Best financial strength rating for U.S. insurance subsidiaries is A(Excellent) with a negative outlook, which could impact competitive position.
• Leverage ratio increased to 28.5% at September 30, 2025, from 26.6% at December 31, 2024.
• Fleming filed a motion for reconsideration after the court granted the company's motion to dismiss Fleming's lawsuit, indicating ongoing legal uncertainty.

Risks

• Inherent uncertainty in estimating loss and loss adjustment expense reserves, with potential for incurred losses to be greater than estimates.
• Risk of inaccurate estimates and judgments in risk management leading to greater unintended exposures.
• Potential for downgrades in financial strength ratings of regulated insurance subsidiaries, impacting competitive position and ability to attract/retain business.
• Uncertain outcome of ongoing litigation with Fleming related to the sale of the casualty reinsurance business.
• Potential loss of key management or employees and challenges in attracting and retaining personnel.
• Adverse economic and competitive factors that could lead to fewer policy sales or increased claim frequency/severity.
• Impact of higher than expected inflation on reserves, loss adjustment expenses, investment values, and compensation.
• Exposure to credit risk, interest rate risk, and other market risks in the investment portfolio and with reinsurers.
• Reliance on a select group of brokers, agents, and customers for a significant portion of business.
• Challenges in obtaining adequate insurance and reinsurance coverage at favorable prices and terms.
• Losses from reinsurance counterparties failing to pay claims or indemnifying parties failing to perform reimbursement obligations.
• Inadequacy of premiums charged to compensate for incurred losses.
• Potential adverse tax consequences for U.S. federal income tax purposes for certain holders of JRG Holdings Stock as a result of the Domestication, including potential PFIC rules application.
• Changes in laws or government regulations, including tax or insurance laws, which may be retroactive.
• Losses from catastrophic events exceeding expectations or reinsurance coverage.
• Potential effects of emerging claim and coverage issues on the business.
• Risks from internal or external fraud, operational errors, system malfunctions, or cybersecurity incidents.
• Challenges in effectively managing growth.
• Failure to maintain effective internal controls in accordance with the Sarbanes-Oxley Act.
• Restrictions on subsidiaries' ability to pay dividends due to changes in financial condition or regulations.
• Differences in shareholder rights and increased likelihood of costly litigation following the domestication to Delaware.

Future Outlook

The company anticipates a lower effective tax rate following the planned domestication from Bermuda to Delaware, expected around November 7, 2025. Management continues to evaluate the impact of the One Big Beautiful Bill Act (OBBBA) but does not expect a material effect on consolidated financial statements. New accounting standards (ASU 2023-09 and ASU 2024-03) are primarily disclosure-related and are not expected to materially impact financial statements. Management intends to hold available-for-sale securities in an unrealized loss position until recovery, not expecting to be required to sell them prematurely.

Management Comments

• "The Company produced net income from continuing operations of $1.6 million and adjusted net operating income of $17.4 million for the three months ended September 30, 2025 compared to a net loss from continuing operations of $38.1 million and an adjusted net operating loss of $28.2 million for the three months ended September 30, 2024."
• "The net loss from continuing operations and adjusted net operating loss in the prior year quarter was largely attributable to $57.0 million of adverse development recorded in the Excess and Surplus Lines segment including a $52.2 million reserve charge upon execution of the E&S ADC (consideration paid in excess of initial reserves)."
• "Growth in tangible common equity of 10.1% in the current quarter was largely driven by net income and unrealized gains on fixed maturities in other comprehensive income due to a decline in interest rates."
• "Our 19.3% adjusted net operating return on tangible common equity for the three months ended September 30, 2025 compares to a 32.8% loss for the three months ended September 30, 2024."
• "Given changes in our underwriting appetite, we are being selective in certain lines of business."
• "The Company's strategy to remain opportunistic in the current market environment and manage this segment to retain minimal risk."
• "Management believes that the lack of economic impact of retroactive reinsurance accounting makes the presentation of our key metrics on business not subject to retroactive reinsurance accounting helpful to the users of our financial information."
• "Management does not intend to sell available-for-sale securities in an unrealized loss position, and it is not more likely than not that the Company will be required to sell these securities before a recovery in their value to their amortized cost basis occurs."

Industry Context

The company's return to underwriting profitability in its Excess and Surplus Lines segment, coupled with a disciplined approach to underwriting and a focus on smaller accounts, reflects a strategic response to market conditions and past challenges in the specialty insurance sector. The use of Adverse Development Covers (ADCs) and Loss Portfolio Transfers (LPTs) is a common industry practice for managing long-tail liabilities, particularly in commercial auto and casualty lines, which have experienced significant adverse development across the industry. The decline in gross written premiums in the Specialty Admitted Insurance segment, driven by non-renewals and a strategy to retain minimal risk, indicates a cautious stance in a competitive fronting business market. The A.M. Best negative outlook is a critical industry signal that could impact the company's ability to attract and retain business, as ratings are crucial for competitive positioning in the insurance sector. The planned domestication to Delaware aligns with a trend among some Bermuda-based companies seeking U.S. tax advantages and a more familiar regulatory framework for U.S. investors.

Comparison to Industry Standards

• The combined ratio of 94.0% for Q3 2025 and 97.4% for the nine months ended September 30, 2025, indicates strong underwriting profitability, which is generally considered a positive performance metric in the property and casualty insurance industry, outperforming many peers who may struggle to achieve sub-100% combined ratios.
• The A.M. Best financial strength rating of A(Excellent) is a solid rating within the insurance industry, but the 'negative outlook' suggests potential concerns that could place it below the stability or positive outlooks of some higher-rated competitors.
• The company's strategy of utilizing Loss Portfolio Transfers (LPTs) and Adverse Development Covers (ADCs) for legacy commercial auto and casualty portfolios is a standard risk management tool, comparable to actions taken by other insurers to de-risk and manage long-tail liabilities, such as Enstar Group Limited's role as a counterparty in the E&S Top Up ADC, which is a prominent player in the run-off market.
• The decline in gross written premiums, particularly in the Specialty Admitted Insurance segment, reflects a more selective underwriting approach, which, while impacting top-line growth, can lead to improved underwriting profitability, a trade-off often seen across the industry when companies prioritize profitability over premium volume in challenging market segments.

Management Changes

Corporate Governance

Legal Proceedings

• The company filed a complaint against Fleming on March 11, 2024, alleging breach of the Stock Purchase Agreement for JRG Re. A preliminary injunction was granted on April 6, 2024, compelling Fleming to close the transaction, which it did on April 16, 2024. Fleming withdrew its appeal on October 9, 2024.
• Fleming filed a lawsuit against JRG Holdings and certain officers on July 15, 2024, alleging claims under the Securities Exchange Act of 1934, common law fraud, and breaches of contract related to the JRG Re sale. The company's motion to dismiss this lawsuit was granted on July 17, 2025. Fleming filed a motion for reconsideration on August 14, 2025.

Related Party Transactions

• Series A Preferred Shares are held by GPC Partners Investments (Thames) LP, an affiliate of Gallatin Point Capital LLC. Matthew Botein, a director, is the Series A Designee.
• The Commercial Auto Loss Portfolio Transfer (LPT) is with Aleka Insurance, Inc., a captive insurance company affiliate of Rasier LLC, and the company has indemnity agreements with Rasier.
• The E&S Top Up Adverse Development Cover (ADC) is with Cavello Bay Reinsurance Limited, a subsidiary of Enstar Group Limited. Enstar also purchased $12.5 million of the company's common shares.

Stakeholder Impact

• **Shareholders:** Positive impact from improved financial performance and underwriting profitability, but negative impact from reduced common share dividends and potential dilution from increased authorized shares for equity plans. U.S. federal income tax consequences may arise from the domestication.
• **Employees:** Compensation expenses in the Corporate and Other segment were reduced. Share-based compensation plans remain active.
• **Customers:** The company's selective underwriting in Excess and Surplus Lines and reduced risk retention in Specialty Admitted Insurance may affect the availability or terms of coverage for some customers.
• **Reinsurers:** Continued reliance on reinsurers for risk transfer, with credit exposure if reinsurers fail to meet obligations. Strategic relationships with State National and Enstar (Cavello Bay) are key.
• **Rating Agencies:** The A.M. Best A(Excellent) rating with a negative outlook is a critical factor influencing the company's ability to attract and retain business.

Next Steps

• The domestication of JRG Holdings from Bermuda to Delaware is expected to be effective on or around November 7, 2025.
• The company will continue to evaluate the impact of the One Big Beautiful Bill Act (OBBBA) and new accounting standards (ASU 2023-09, ASU 2024-03).
• Fleming's motion for reconsideration of the lawsuit dismissal is pending.
• The Board of Directors declared a cash dividend of $0.01 per common share and up to $2.0 million on Series A Preferred Shares, payable on December 31, 2025.
• The performance period for certain Performance Restricted Share Units (PRSUs) extends through December 31, 2027.
• The dividend rate for Series A Preferred Shares will reset on October 1, 2029.

Key Dates

Recommendation

While James River Group Holdings, Ltd. has demonstrated a significant turnaround in underwriting profitability and net income for the quarter and nine months ended September 30, 2025, driven by strategic actions and favorable reserve development, several factors warrant a 'hold' recommendation. The decline in gross written premiums, particularly in the Specialty Admitted Insurance segment, and the negative outlook from A.M. Best for its U.S. insurance subsidiaries, present ongoing headwinds. The company is in a transitional phase with the domestication to Delaware and ongoing legal proceedings with Fleming. The improved financial metrics are positive, but the company needs to demonstrate sustained premium growth and a stable rating outlook to justify a stronger recommendation.

Keywords

Specialty Insurance, Excess and Surplus Lines, Reinsurance, Underwriting Profit, Financial Results, SEC Filing, 10-Q, James River Group, JRVR, Investment Income, Risk Management, Corporate Governance, Capital Management, Domestication, Adverse Development Cover, Loss Portfolio Transfer, Combined Ratio, Shareholders Equity